Tregs secrete anti-inflammatory cytokines including TGF-β, IL-10, and IL-35 into the microenvironment, and thereby suppress the activity of effector immune cells and consequently anti-tumor immunity [93,94,95,96]. The gene discussed is TGFB1; the disease is neoplasm.